MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00392-025-02842-x

Медицинская библиотека · Clinical research in cardiology : official journal of the German Cardiac Society · 2026

Clinical performance of the next generation Elecsys Troponin T high-sensitivity Gen 6 assay in acute coronary syndrome (PERFORM-TSIX): study design.

Daniels Lori B, Giannitsis Evangelos, Mueller Christian, Meex Steven J R, Buehlmann David, Kurtoic Dunja, Bendig Garnet, Cole Mette, Body Richard, Christenson Robert H, Cobbaert Christa, deFilippi Christopher R, Eggers Kai M, Inoue Kenji, Jaffe Allan S, McCarthy Cian P, McCord James, Neumann Johannes T, Omland Torbjørn, Papendick Cynthia, Sandoval Yader, Tan Jack Wei Chieh, Than Martin P, Twerenbold Raphael, Mills Nicholas L, Peacock W Frank, TSIX investigators

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

High-sensitivity cardiac troponin (hs-cTn) assays are the gold standard for the early diagnosis and risk stratification of acute myocardial infarction (AMI). PERFORM-TSIX (clinicaltrials.gov identifier: NCT06734117) is a prospective, international, observational, longitudinal cohort study to evaluate the clinical performance of the next-generation Elecsys® Troponin T hs Gen 6 assay; the study design is presented here.

OBJECTIVES

The primary objective is to determine the sensitivity of the Troponin T hs Gen 6 assay for the detection of centrally adjudicated AMI diagnosis at 3 h post-emergency department (ED) presentation. Secondary objectives include evaluation of clinical performance at 0, 1-, 5-, and 6-h post-ED presentation and validation of thresholds for a 0/1-h algorithm to rule out AMI. Exploratory objectives include validation of thresholds for a 0/1-h algorithm to rule in AMI and a 0/2-h algorithm to rule in/out AMI and evaluation of prognostic performance at 30 and 180 days.

METHODS

PERFORM-TSIX enrolled 5631 participants across 50 sites from the USA, Europe, China, and Japan. Patients aged ≥ 20 years presenting to the ED with symptoms/signs of acute coronary syndrome were enrolled. All patients were required to have cTn measured as part of their routine care; AMI diagnosis was adjudicated by an independent clinical events committee in accordance with the Fourth Universal Definition of MI, blinded to the results of the Troponin T hs Gen 6 assay.

CONCLUSION

PERFORM-TSIX will determine the clinical performance of the Troponin T hs Gen 6 assay for the diagnosis of AMI in a large, diverse global population.

Для цитирования: Daniels Lori B, Giannitsis Evangelos, Mueller Christian, Meex Steven J R, Buehlmann David, Kurtoic Dunja, Bendig Garnet, Cole Mette, Body Richard, Christenson Robert H, Cobbaert Christa, deFilippi Christopher R, Eggers Kai M, Inoue Kenji, Jaffe Allan S, McCarthy Cian P, McCord James, Neumann Johannes T, Omland Torbjørn, Papendick Cynthia, Sandoval Yader, Tan Jack Wei Chieh, Than Martin P, Twerenbold Raphael, Mills Nicholas L, Peacock W Frank, TSIX investigators. Clinical performance of the next generation Elecsys Troponin T high-sensitivity Gen 6 assay in acute coronary syndrome (PERFORM-TSIX): study design.. Clinical research in cardiology : official journal of the German Cardiac Society. 2026. DOI: 10.1007/s00392-025-02842-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.